NARI — Inari Medical Income Statement
0.000.00%
Last trade - 00:00- $4.68bn
- $4.57bn
- $493.63m
Annual income statement for Inari Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 51.1 | 140 | 277 | 383 | 494 |
| Cost of Revenue | |||||
| Gross Profit | 45.3 | 127 | 252 | 339 | 435 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 50.5 | 122 | 266 | 412 | 508 |
| Operating Profit | 0.596 | 17.8 | 10.8 | -28.1 | -14.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.19 | 13.8 | 10.7 | -26.2 | 4.25 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.19 | 13.8 | 9.84 | -29.3 | -1.64 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.19 | 13.8 | 9.84 | -29.3 | -1.64 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.19 | 13.8 | 9.84 | -29.3 | -1.64 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.019 | 0.298 | 0.177 | -0.554 | 0.097 |
| Dividends per Share |